Cite
HARVARD Citation
Gualberto, A. et al. (n.d.). KIR3DL2 MUTATION MAY DEFINE A HIGH RATE OF RESPONSE OF AITL TO TIPIFARNIB. Hematological oncology. p. 204. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gualberto, A. et al. (n.d.). KIR3DL2 MUTATION MAY DEFINE A HIGH RATE OF RESPONSE OF AITL TO TIPIFARNIB. Hematological oncology. p. 204. [Online].